Clinical Trial: Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia
Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia
Brief Summary: Azoospermia due to low sperm production (non-obstructive azoospermia) affects approximately 1% of the male population and 10% of men who seek fertility evaluation. Testis biopsy reveals that these men have Sertoli cell-only pattern, maturation arrest, or hypospermatogenesis. Until recently, it was assumed that men with non-obstructive azoospermia were untreatable. Indeed, these patients were often referred to as being "sterile" or having "testicular failure." We start to use stem cell in treatment of such patients by injecting the stem cell at the testis and the testicular artery in one group and at the testis only in other group
Detailed Summary:
Sponsor: Man Clinic for Andrology, Male Infertility and Sexual Dysfunction
Current Primary Outcome: Semen Analysis [ Time Frame: Three to six months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Inhibin B Hormone [ Time Frame: Three to six months ]
Original Secondary Outcome: Same as current
Information By: Man Clinic for Andrology, Male Infertility and Sexual Dysfunction
Dates:
Date Received: December 8, 2013
Date Started: January 2013
Date Completion: December 2016
Last Updated: April 7, 2015
Last Verified: April 2015